Suppr超能文献

从RORγt激动剂到两类RORγt反向激动剂。

From RORγt Agonist to Two Types of RORγt Inverse Agonists.

作者信息

Wang Yonghui, Cai Wei, Tang Ting, Liu Qian, Yang Ting, Yang Liuqing, Ma Yingli, Zhang Guifeng, Huang Yafei, Song Xiaoxia, Orband-Miller Lisa A, Wu Qianqian, Zhou Ling, Xiang Zhijun, Xiang Jia-Ning, Leung Stewart, Shao Liming, Lin Xichen, Lobera Mercedes, Ren Feng

机构信息

School of Pharmacy, Fudan University, 826 Zhangheng Road, Pudong, Shanghai 201203, China.

Research and Development, GlaxoSmithKline, No. 3 Building, 898 Halei Road, Pudong, Shanghai 201203, China.

出版信息

ACS Med Chem Lett. 2018 Jan 22;9(2):120-124. doi: 10.1021/acsmedchemlett.7b00476. eCollection 2018 Feb 8.

Abstract

Biaryl amides as new RORγt modulators were discovered. The crystal structure of biaryl amide agonist in complex with RORγt ligand binding domain (LBD) was resolved, and both "short" and "long" inverse agonists were obtained by removing from or adding to a proper structural moiety. While "short" inverse agonist () recruits a corepressor peptide and dispels a coactivator peptide, "long" inverse agonist () dispels both. The two types of inverse agonists can be utilized as potential tools to study mechanisms of Th17 transcriptional network inhibition and related disease biology.

摘要

发现了作为新型RORγt调节剂的联芳基酰胺。解析了联芳基酰胺激动剂与RORγt配体结合域(LBD)复合物的晶体结构,并通过从适当结构部分去除或添加来获得“短”和“长”反向激动剂。“短”反向激动剂()募集共抑制肽并驱散共激活肽,而“长”反向激动剂()则驱散两者。这两种类型的反向激动剂可作为研究Th17转录网络抑制机制和相关疾病生物学的潜在工具。

相似文献

1
From RORγt Agonist to Two Types of RORγt Inverse Agonists.
ACS Med Chem Lett. 2018 Jan 22;9(2):120-124. doi: 10.1021/acsmedchemlett.7b00476. eCollection 2018 Feb 8.
2
Discovery of N-(4-aryl-5-aryloxy-thiazol-2-yl)-amides as potent RORγt inverse agonists.
Bioorg Med Chem. 2015 Sep 1;23(17):5293-302. doi: 10.1016/j.bmc.2015.07.068. Epub 2015 Aug 1.
5
Discovery of carbazole carboxamides as novel RORγt inverse agonists.
Eur J Med Chem. 2018 Mar 25;148:465-476. doi: 10.1016/j.ejmech.2018.02.050. Epub 2018 Feb 16.
6
Discovery of Tertiary Amine and Indole Derivatives as Potent RORγt Inverse Agonists.
ACS Med Chem Lett. 2013 Nov 22;5(1):65-8. doi: 10.1021/ml4003875. eCollection 2014 Jan 9.
7
Discovery of carboxyl-containing biaryl ureas as potent RORγt inverse agonists.
Eur J Med Chem. 2020 Sep 15;202:112536. doi: 10.1016/j.ejmech.2020.112536. Epub 2020 Jul 5.
9
6-Substituted quinolines as RORγt inverse agonists.
Bioorg Med Chem Lett. 2017 Dec 1;27(23):5277-5283. doi: 10.1016/j.bmcl.2017.10.027. Epub 2017 Oct 16.

引用本文的文献

1
Statistical Analysis of Protein-Ligand Interaction Patterns in Nuclear Receptor RORγ.
Front Mol Biosci. 2022 Jun 15;9:904445. doi: 10.3389/fmolb.2022.904445. eCollection 2022.
3
(Inverse) Agonists of Retinoic Acid-Related Orphan Receptor γ: Regulation of Immune Responses, Inflammation, and Autoimmune Disease.
Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:371-390. doi: 10.1146/annurev-pharmtox-010919-023711. Epub 2019 Aug 6.
4
Molecular dynamics simulations on RORγt: insights into its functional agonism and inverse agonism.
Acta Pharmacol Sin. 2019 Nov;40(11):1480-1489. doi: 10.1038/s41401-019-0259-z. Epub 2019 Jul 17.

本文引用的文献

1
RORγ antagonists and inverse agonists: a patent review.
Expert Opin Ther Pat. 2017 Jan;27(1):101-112. doi: 10.1080/13543776.2017.1236918. Epub 2016 Sep 29.
2
Recent progress on nuclear receptor RORγ modulators.
Bioorg Med Chem Lett. 2016 Sep 15;26(18):4387-4393. doi: 10.1016/j.bmcl.2016.08.012. Epub 2016 Aug 6.
3
Discovery of N-(4-aryl-5-aryloxy-thiazol-2-yl)-amides as potent RORγt inverse agonists.
Bioorg Med Chem. 2015 Sep 1;23(17):5293-302. doi: 10.1016/j.bmc.2015.07.068. Epub 2015 Aug 1.
4
Discovery of Biaryl Amides as Potent, Orally Bioavailable, and CNS Penetrant RORγt Inhibitors.
ACS Med Chem Lett. 2015 May 26;6(7):787-92. doi: 10.1021/acsmedchemlett.5b00122. eCollection 2015 Jul 9.
5
Minor Structural Change to Tertiary Sulfonamide RORc Ligands Led to Opposite Mechanisms of Action.
ACS Med Chem Lett. 2014 Dec 4;6(3):276-81. doi: 10.1021/ml500420y. eCollection 2015 Mar 12.
6
ROR nuclear receptors: structures, related diseases, and drug discovery.
Acta Pharmacol Sin. 2015 Jan;36(1):71-87. doi: 10.1038/aps.2014.120. Epub 2014 Dec 15.
7
Targeting Th17 cells in autoimmune diseases.
Trends Pharmacol Sci. 2014 Oct;35(10):493-500. doi: 10.1016/j.tips.2014.07.006. Epub 2014 Aug 14.
8
Targeting Th17 cells in immune diseases.
Cell Res. 2014 Aug;24(8):901-3. doi: 10.1038/cr.2014.92. Epub 2014 Jul 15.
9
Discovery of Tertiary Amine and Indole Derivatives as Potent RORγt Inverse Agonists.
ACS Med Chem Lett. 2013 Nov 22;5(1):65-8. doi: 10.1021/ml4003875. eCollection 2014 Jan 9.
10
Inhibiting RORγt/Th17 axis for autoimmune disorders.
Drug Discov Today. 2014 Aug;19(8):1205-11. doi: 10.1016/j.drudis.2014.04.012. Epub 2014 Apr 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验